Andrew Biankin
www.gla.ac.uk
0000-0002-0362-5597
University of Glasgow
4 papers found
Refreshing results…
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
Missing publications? Search for publications with a matching author name.